glp 1 for cardiovascular disease The effects of GLP-1 receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action How are GLP-1 drugs reshaping

Tirzepatide commonly causes nausea, vomiting, diarrhea, and decreased appetite, particularly during dose escalation

And physical activity can offer relief from semaglutide bloating

International Journal of Food Science, 2019 , 4138534

When experiencing symptoms of dizziness or lightheadedness, patients should check their blood glucose to differentiate hypotension from hypoglycemia, as symptoms can overlap

60 HolstJJGromadaJNauckMA

The New Aesthetic Landscape: Addressing the GLP-1 "Gap" The aesthetic industry is currently undergoing a seismic shift driven by the explosion of GLP-1 medications (such as Ozempic and Wegovy)